CEOs Start Saying the Quiet Part Out Loud: AI Will Wipe Out Jobs
Ford chief predicts AI will replace “literally half of all white-collar workers.”
—-
U.S. Eases Some Chip Software Curbs on China
The U.S. has lifted some curbs on exports of chip-design software to China, according to two companies that say they are working to restore access to recently restricted products.
—-
Tesla Is in Disarray. Musk Has Already Moved Beyond Caring About Cars.
The electric-vehicle maker has an aging lineup and slumping sales, but its CEO has shifted his focus to robotaxis and robots.
—-
Microsoft to Lay Off About 9,000 Workers
The cuts represent less than 4% of the company’s global workforce and come on top of about 6,000 roles it eliminated in May.
—-
Big Banks Keep Winning-and So Do Their Stocks
Laxer regulations and a likely drop in interest rates is spurring investor interest in the big banks.
—-
Inside Trump and Paramount’s Wrangling Over the ’60 Minutes’ Settlement
Concerns about bribery allegations, angry CBS News staff and a looming high-stakes merger made for tense monthslong negotiations.
—-
Starboard Takes More Than 9% Stake in Tripadvisor
The travel-review company’s shares have fallen after it rejected takeover offers last year.
—-
Del Monte Foods Files for Bankruptcy After Post-Pandemic Consumer Pullback
The packaged-foods company has lined up $165 million in new bankruptcy loans and hopes to sell its assets as going concerns.
—-
Advanced Micro Devices CEO to Get Raise, $33 Million Equity Award
All of the five AMD executives included in the securities filing are getting a raise between 3% and 5%.
—-
Lucid Group Vehicle Deliveries Rise
Lucid delivered 3,309 vehicles in the second quarter, 200 more than in it did the prior quarter and above the 2,394 delivered in the same period a year earlier, the company said.
—-
Centene Faces Earnings Crunch as More Healthy Americans Exit Insurance Plans
The health-insurance provider is reckoning with multiple threats to its business, potentially leaving it with fewer and less-healthy enrollees signed up to its health-insurance plans.
—-
Continental Expects Limited Autos Hit From U.S. Tariffs
Continental said it expects its automotive division to face a limited impact from U.S. tariffs on auto parts due to a high share of imports that comply with the USMCA trade agreement.
—-
Regeneron Gets Accelerated FDA OK of Lynozyfic for Blood Cancer Treatment
Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood cancer multiple myeloma.
(END) Dow Jones Newswires
July 03, 2025 03:15 ET (07:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.